Libmyris
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Libmyris, covering 2026-03-19 to 2026-07-13. Get the full timeline:
Most recent: EMA Authorised: Libmyris (adalimumab) — Stada Arzneimittel AG
2 regulatory and trial events tracked for Libmyris, covering 2026-03-19 to 2026-07-13. Get the full timeline:
Most recent: EMA Authorised: Libmyris (adalimumab) — Stada Arzneimittel AG